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ABSTRACT We present a joint theoreti-
cal and experimental study on the
effects of competition for ligand
between receptors in solution and
receptors on cell surfaces. We focus
on the following experiment: After
ligand and cell surface receptors equili-
brate, solution receptors are intro-
duced, and the dissociation of surface
bound ligand is monitored. We derive
theoretical expressions for the disso-
ciation rate and compare with experi-
ment. In a standard dissociation experi-
ment (no solution receptors present)
dissociation may be slowed by rebind-
ing, i.e., at high receptor densities a
ligand that dissociates from one recep-
tor may rebind to other receptors
before separating from the cell. Our
theory predicts that rebinding will be
prevented when S >> N2Kon/ ( 167r2D a4),
where S is the free receptor site con-
centration in solution, N the number of
free surface receptor sites per cell, Kon
the forward rate constant for ligand-
receptor binding in solution, D the diffu-
sion coefficient of the ligand, and a the
cell radius. The predicted concentra-
tion of solution receptors needed to
prevent rebinding is proportional to the
square of the cell surface receptor
density. The experimental system used
in these studies consists of a monova-
lent ligand, 2,4-dinitrophenyl (DNP)-
aminocaproyl-L-tyrosine (DCT), that
reversibly binds to a monoclonal anti-
DNP immunoglobulin E (IgE). This IgE is
both a solution receptor and, when
anchored to its high affinity Fc, recep-
tor on rat basophilic leukemia (RBL)
cells, a surface receptor. For RBL cells
with 6 x 105 binding sites per cell, our
theory predicts that to prevent DCT
rebinding to cell surface IgE during
dissociation requires S >> 2,400 nM. We
show that for S = 200-1,700 nM, the
dissociation rate of DCT from surface
IgE is substantially slower than from
solution IgE where no rebinding occurs.
Other predictions are also tested and
shown to be consistent with experi-
ment.
INTRODUCTION
The binding of a ligand to a cell surface receptor is the
first step in a cascade of events that leads to the genera-
tion of a transmembrane signal. In many cases such
binding occurs in the presence of receptors in solution that
compete with cell surface receptors for the ligand. For
example, B cells are stimulated by antigen binding to
their surface immunoglobulin, and this occurs in vivo in
the presence of secreted antibodies of the same specificity.
In many allergic reactions of the immediate hypersensi-
tive type, solution antibody (usually IgG) competes for
the same antigenic sites with IgE that is bound via high
affinity Fc, receptors to the surface of mast cells and
basophils (Lichtenstein et al., 1968; Ottesen et al., 1981;
Golden et al., 1982). Retroviruses, including human
immunodeficiency virus (HIV), shed envelope proteins
(Gelderbom et al., 1987) which may compete with their
surface counterparts for antibody that bind these pro-
teins. The envelope glycoprotein gpl 20 of HIV-1 binds to
its cellular receptor, CD4, on T cells, macrophage, and
other cell types. Soluble forms of CD4 have been pro-
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duced and, in vitro, have been used to compete with cell
surface CD4 and prevent the attachment of HIV-1 to
human T cells (Smith et al., 1987; Fisher et al., 1988;
Hussey et al., 1988; Deen et al., 1988, Traunecker et al.,
1988). Patients with HTLV-I-positive adult T cell leuke-
mia have greatly elevated levels of a low affinity receptor
(the Tac antigen) that binds interleukin 2 (IL 2). The
HTLV-I-positive T cell line HUT 102B2 releases a
soluble form of this receptor which binds IL 2 normally
and therefore can compete with cell surface IL 2 recep-
tors for this ligand (Rubin et al., 1986).
We seek to study the effects on a ligand-cell surface
receptor system of adding solution receptors that bind the
same ligand. We start with an equilibrium solution of
ligand and cell surface receptors. We then add solution
receptors and follow the kinetics of dissociation of surface
bound ligand. At equilibrium, bound ligands are con-
stantly dissociating from cell surface receptors and mov-
ing into solution while, at the same rate, free ligands are
moving from solution and binding to cell surface recep-
tors. When solution receptors are added, some free ligand
that in the absence of these receptors would have returned
to bind to cell surface receptors, binds instead to receptors
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in solution. Still, other ligands may rebind to surface
receptors many times before binding to a receptor in
solution. With time the system will move to a new
equilibrium. When the surface receptor density is suffi-
ciently high rebinding can greatly slow the dissociation of
bound ligand from the cell surface (Erickson et al., 1987).
One obvious question which we attempt to answer here is:
What concentration of solution receptors is required to
block rebinding? A more general question that we address
is: How does the kinetics of dissociation depend on the
concentrations of solution and cell surface receptors?
First we present a theoretical description of the disso-
ciation, which is based on previous theoretical studies that
have been used successfully to describe the effects of cell
surface receptor density on the binding and dissociation of
ligands from cell surfaces when no solution receptors are
present (Berg and Purcell, 1977; Berg 1978; DeLisi 1980,
1981; DeLisi and Wiegel, 1981; Shoup and Szabo, 1982).
We then study experimentally the dissociation of a mono-
valent ligand; 2,4-dinitrophenyl (DNP)-aminocaproyl-
L-tyrosine (DCT), that reversibly binds to a bivalent
receptor, a monoclonal anti-DNP immunoglobulin E
(anti-DNP IgE) (Liu et al., 1980). This anti-DNP IgE is
both a solution receptor and, when anchored to its high
affinity Fc, receptor on rat basophilic leukemia (RBL)
cells, a cell surface receptor. Previously we used this
system to study the effects of cell surface receptor density
on the rate of ligand binding to cell surface receptors, in
the absence of solution receptors (Erickson et al., 1987).
This experimental system is well suited for the present
studies because we can control both the solution and cell
surface receptor concentrations, varying the latter con-
centration between 0 and -6 x 105 sites/cell.
MATERIALS AND METHODS
previously (Erickson et al., 1986). All fluorescence recordings were
made as previously described on a spectrofluorimeter (model 8000;
SLM Instruments, Inc., Urbana, IL) in ratio mode with FITC excita-
tion and emission wavelength 490 and 526 nm, respectively. A CS-71
longpass filter (No. 3384: Corning Glass Works, Corning Science
Products, Corning NY) was used in the emission port to reduce
scattered light contributions. The spectrofluorimeter was interfaced
with an AST Premium 286 computer for direct data acquisition.
For each dissociation experiment, 2 ml of a labeled cell suspension or
labeled IgE in solution were placed in a 10 x 10 x 48 mm acrylic cuvette
and stirred continuously. Sufficient DCT was added via microcapillary
tubes to saturate the Fab binding sites, thereby quenching the FITC
fluorescence (maximally by -20%). After the fluorescence decrease was
complete, varying amounts of unlabeled anti-DNP IgE were added to
the suspension with a calibrated Finnpipette (Labsystems OY, Pulttitie
9, 00810, Helsinki 81, Finland). Mixing times were <2 s. The rate of
dissociation of the DCT from the Fab sites was monitored as the
consequent increase of fluorescence with time. Data points were
recorded at 2.4 s intervals. All experiments were done at 150C.
Parameter estimation
Our parameter estimates were obtained using the International Mathe-
matics and Statistics Library (IMSL) routine ZXSSQ, which is based
on a finite difference, Levenberg-Marquardt algorithm for solving
nonlinear least squares problems.
For a monovalent ligand binding to a receptor site in solution we
determined the equilibrium binding constant K as follows: The concen-
tration of bound ligand L* = KRTL/(1 + KL), where L= LT - L* is
the free ligand concentration, LT the total ligand concentration and RT
the total receptor site (Fab sites) concentration. Solving for L* we have
that
L* 1 + KLT + KRT - [(1 + KLT + KRT)2 - 4K2RTLT]1/2
2K
L* is related to the relative fluorescence F, since binding leads to
quenching of the fluorescence. In particular, L*/LT = I - (F - F1)/
(F2 - F,), where F1 is the relative fluorescence when all receptor sites
are free and F2 is the relative fluorescence when all receptor sites are
filled. To determine K we fit the above equation to a fluorescence
titration curve taking as free parameters K, Fl, and F2.
Sensitization of cells with labeled
IgE and fluorescence
measurement of bound ligand
Procedures for maintaining the RBL (subline 2H3) cells, for prepara-
tion of labeled IgE, and for binding IgE to its receptors on the RBL cells
have been described previously (Erickson et al., 1986; Erickson et al.,
1987). Cell receptors for IgE were saturated with varying ratios of 1251I
and fluorescein-5-isothiocyanate (FITC) labeled mouse IgE (specific
for DNP) and unlabeled rat IgE (which does not bind DNP) such that
the cells had varying surface densities of the labeled anti-DNP IgE.
Fluorescence microscopy of the labeled cells showed a characteristic
smooth green ring stain around the equator of the spherical cells and
essentially no intracellular fluorescence. The cell concentration was
determined by counting with a microscope and hemocytometer. The
specific activity of '25I-IgE, determined as previously described (Erick-
son et al., 1986), allowed us to calculate the number of receptors for
DNP ligands per cell.
The proportionate decrease in FITC-IgE fluorescence that accompa-
nies Fab site occupation by DNP-ligands has been described in detail
RESULTS
Theoretical
When receptors are clustered in space, as when they are
confined to cell surfaces, their rates of binding can be
quite different than when they are uniformly distributed
in solution. When the density of free cell surface receptors
is sufficiently high, a ligand will rapidly bind to a receptor
once it is near the cell surface, and the rate at which the
ligand binds to a receptor will be limited by the rate at
which the ligand diffuses to the cell surface. For such high
cell surface receptor densities, theory predicts (Berg and
Purcell, 1977; Berg, 1978; DeLisi, 1980, 1981; DeLisi and
Wiegel, 1981; Brunn, 1981; Shoup and Szabo, 1982) that
both the forward and reverse rate constants for ligand-
receptor binding will be reduced. The forward rate con-
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stant will be reduced because nearby receptors compete
for the same ligand. The reverse rate constant will be
reduced because a ligand that dissociates from one recep-
tor is likely to bind to another receptor, rather than move
away from the cell. If kf and k, are the forward and
reverse rate constants for the binding of a ligand to a
monovalent cell surface receptor, then theory predicts
that for a cell with N free binding sites on its surface
(Shoup and Szabo, 1982)
kf Kon(1)
+ NK0,/k+(1
k Koff (2)
+ NK0,/k+'
where Kon and Koff are the reaction limited forward and
reverse rate constants for the binding of a ligand to an
isolated cell surface receptor (i.e., to a cell surface recep-
tor when the average separation distance between recep-
tors is very large and the time to diffuse to the cell is
negligible) and k+ is the diffusion limited forward rate
constant for binding of a ligand to the cell. The rate
constant k+ characterizes the transport of ligands from
solution to the vicinity of the cell surface, while the rate
constant Kon characterizes the binding of ligands to single
receptors.
If the cell is modeled as a sphere of radius a then k+ is
just the Smoluchowski diffusion-controlled rate constant,
i.e.,
k+ = 4irDa, (3)
In Eq. 4 Kon is the forward rate constant for the binding
of a ligand to a receptor in solution. We have assumed
that Kon is the same for a receptor in solution and on a cell
surface. (If this is not so the Kon in Eqs. 1 and 2 will differ
from the Kon in Eq. 4. For the experimental system we use
here, we have directly determined K0n for IgE both in
solution and on RBL cells, and shown them to be the same
(Erickson et al., 1987). Thus, the ligand binding proper-
ties of our receptor, a monoclonal anti-DNP IgE (Liu et
al., 1980), are unchanged when the IgE is bound to its Fc,
receptor on RBL cells.
From Eqs. 1, 2, and 4 we predict that the rate constants
for a ligand interacting with a cell surface receptor in the
presence of receptors in solution with identical binding
properties are:
kf = Kon
I + ~NKon
47rDa [1 + (K0nSa2/D)"/2]
kr= Koff
+ NKon
4irDa [1 + (KonSa2/D)'/2]
(5)
(6)
We can now determine when the presence of receptors in
solution will block the rebinding of dissociated ligand to
the cell surface. From Eq. 2 we see rebinding will be
negligible and k, Koff when NKO0/k+ << 1. It follows from
Eqs. 4 and 6 that this inequality will always be satisfied if
NK00/(4lrDa(K00Sa2ID)"12) << 1. This inequality can be
rewritten in the following form:
where D is the diffusion coefficient of the ligand. With
this value of k+ we see from Eq. 2 that the quantity
1/(1 + NK00/4lrDa) is the fraction of molecular dissocia-
tions that lead to true separations of the ligand from the
cell (Berg, 1978). When NK00/(4lrDa) >> 1 this fraction
will be small and dissociation from the cell surface will be
much slower than dissociation from an isolated receptor.
Eqs. 1-3 were obtained assuming there were no recep-
tors in solution. When receptors are present in solution
Eqs. 1 and 2 are still valid, but k+ is no longer given by Eq.
3. As we show in the Appendix, if we let S be the
concentration of free receptor binding sites in solution,
and assume that S is sufficiently large that we can treat
the binding of a ligand to a solution receptor as irrevers-
ible, then
k+ = 47rDa[1 + (K0,,Sa2/D)'12] . (4)
Note that k+ increases with increasing free receptor
concentration. This must be so if increasing S is to prevent
rebinding. In particular, Eqs. 1 and 2 show that as k+
increases, the effects of diffusion decrease until, when
NK00/k+ << 1, they become negligible. The dependence of
k+ on S is discussed in more detail in the Appendix.
KD,K N 12
D [4ira2J
(7a)
When this inequality is satisfied the concentration of free
receptor sites in solution, S, is sufficiently high to prevent
rebinding. The most interesting feature of this result is
that the solution concentration required to prevent
rebinding increases with the square of the free surface
receptor concentration.
It is instructive to rewrite Eq. 7a in the following form
N
47ra2X (7b)
The quantity X = NFD/(K00S) is the screening length and,
as discussed in the Appendix, is the distance from the cell
surface over which most of the variation in the ligand
concentration occurs. This inequality indicates that when
a >> X, the cell surface receptors have an effective three
dimensional concentration that can be obtained by uni-
formly distributing them in a shell about the cell whose
height equals the screening length. (This effective three
dimensional concentration is only appropriate for the
competition experiment we are considering and is not a
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general prescription for obtaining effective three dimen-
sional concentrations for two dimensional surface concen-
trations.)
With these expressions for ligand-cell surface receptor
rate constants in the presence of solution receptors, Eqs. 5
and 6, we can write down the chemical rate equations that
describe the kinetics of binding and dissociation for this
system. Calling N and NT the free and total cell surface
receptor site concentration, S and ST the free and total
solution receptor site concentration, and L and L? the free
and total ligand concentration, we have that
dNd
-kfLN + kr(NT- N) (8)
dt
dS
=-konLS + koff(ST- S) (9)
dt
LT = L + (ST- S) + (NT- N)p/6.02 x 1011, (10)
where p is the cell concentration in cells/ml. The units of
NT and N are sites/cell while all other concentrations are
in nanomolars. Below we will use the following notation: a
bar over N indicates a bulk cell surface receptor site
concentration in nanomolars, e.g., N = Np/6.02 x 10".
Note that kf and k, are not constant in Eq. 8, but
functions of S and N, given by Eqs. 5 and 6.
We derived Eqs. 5 and 6 in the steady state. We now
use these steady-state rate constants in Eqs. 8 and 9,
which describe the time evolution of the system. We
expect that as long as there are not rapid changes in the
concentrations these steady state expressions will give a
good description of the dissociation of ligand from the cell
surface. As yet we do not have a rigorous condition that
specifies when such a formulation is valid. However, for
the parameter values used here we have found good
agreement between the predictions obtained by numeri-
cally solving Eqs. 8-10 and the numerical solutions of the
partial differential reaction diffusion problem with spher-
ical symmetry (Torney and Goldstein, unpublished
results).
For a dissociation experiment ligand and cell surface
receptor are first in equilibrium and no solution receptor
is present, and then the experiment is initiated at t = 0
when solution receptors at concentration ST are added.
The initial (t = 0) concentrations are
(dN/dt = 0) in the absence of solution receptors
(ST = S = 0).
In general, for a given set of initial concentrations, we
must solve Eqs. 8-10 by numerical integration. However,
when a high concentration of solution receptors is added
so that the free ligand concentration in solution rapidly
falls to its final equilibrium value, we obtain considerable
simplification. If Seq and L¢q are the equilibrium values of
the free solution receptor and free ligand concentrations
at the end of the experiment, then for large solution
receptor concentrations we expect S and L to rapidly take
on these values and then remain essentially constant as N
slowly decays to its final value. In the Appendix we use
the methods of Segel and Slemrod (1989) to derive
conditions under which this quasi-equilibrium approxi-
mation is valid.
When we set L = L4q in Eq. 8 and S = S,q in Eqs. 5 and
6, and substitute these expressions into Eq. 8, we can
integrate Eq. 8 to obtain the following transcendental
equation for n = N/NT, the fraction of free surface
receptor sites, as a function of t:
4NTn,q(n - no) + n,q(1 + 4DNTnfq)
*In Eq ]=-Kfft, (12a)
nwe- no
where,
(Di _, Kon
47rDa [1 + (K'nScqa2/D)'/2] (12b)
no = NO/N, is the fraction of cell surface binding sites that
are free at the start of the experiment (t = 0), n0q =
NC,q/NT is the fraction free at the end of the experiment(t = oc), and n is the fraction free at time t.
For comparison with experimental data, it is useful to
write Eq. 1 2a in terms of the following variable:
=n - no-no
nO- no (13)
Weseethatx = Oatt = Oandx = 1 att= .
In terms of x, Eq. 12a becomes
(1 - )x + In (1 -x) = -km()t, (14)
where
SO = ST
-(KLT-KNT + 1) +[(KLT-KNT + 1)2 + 4KNT] 1/2 ( 11)
2K
Lo = LT- NT + N,O
where K = Kon/Koff = kf/kr. The expressions for No and Lo
were obtained by solving Eqs. 8 and 10 at equilibrium
1 + tNo km(oo)
I + tNeq km(°)
km= kr + kfLe = Ko1 + KOcLq
(15)
(16)
The parameter km(oo) is obtained from Eq. 16 by setting
N = N0,, and is the value km approaches as t cc. The
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initial rate constant for dissociation, km(O), is obtained
from Eq. 16 by setting N = No. That 6 = km (c)/km(O)
comes from the definitions of km(mo) and km(O).
Note the short and long time limits of Eq. 14. As t -- 0,
x 0, and therefore ln(1- x) z -x. When we substi-
tute this approximation into Eq. 14 we find that
lim x = km(O)t .
t-0
(17a)
In the limit that t - o, x - 1 and therefore the
logarithmic term in Eq. 14 becomes infinite while the
linear term remains finite. We can therefore neglect the
linear term so that
(17b)lim x = 1 -e-km(-)t
t-X
Eqs. 17a and b show that the initial and final rate
constants for dissociation from a cell surface receptor are
given by Eq. 16 with N = NO and N = NT, respectively.
The maximum rate of dissociation occurs at the start of
the experiment when the number of free cell surface
receptor sites is a minimum. As dissociation continues
more sites become free, which increases the likelihood of
rebinding and therefore slows dissociation.
In summary, we have derived an approximate equation,
Eq. 14, which describes the dissociation of bound ligand
from cell surface receptors in the presence of a high
concentration of solution receptors. In the Appendix we
discuss in detail the conditions under which Eq. 14 is
valid.
In Table 1 we list the symbols, and their definitions,
that we will frequently use in the text.
Experimental
To study the dissociation of ligand from cell surface
receptors in the presence of solution receptors we use a
monoclonal anti-DNP IgE (Liu et al., 1980) as both the
solution and the cell surface receptor. The IgE, when
acting as a cell surface receptor, is bound to high affinity
Fc, receptors on RBL cells. Estimates of the half-life for
dissociation of IgE from its Fc, receptor on RBL cells
range from 7 to 45 h (Isersky et al., 1979; Wank et al.,
1983). Because these times are much longer than the
times for our kinetic experiments, which typically run for
<30 min, the IgE concentration on the RBL cell surface
remains constant during our experiments. To measure the
rate at which surface IgE binding sites that were initially
occupied by ligand become free, we use a fluorescein-
modified IgE as the cell surface receptor. Previously we
showed that the fraction of IgE sites bound to ligand can
be determined by measuring the fluorescence quenching
that accompanies DNP binding to fluorescein isothiocya-
TABLE i List of frequently used symbols
Symbol Definition
a Cell radius
D Diffusion coefficient of the ligand in solution
6 Ratio of km(-) to km(O)
F Relative fluorescence
F..x Relative fluorescence after dissociation has gone
to completion
Fmin Relative fluorescence immediately after addition
of solution IgE
kf Forward rate constant for the binding of a ligand
to a cell surface receptor binding site
kr Reverse rate constant for the dissociation of a li-
gand from a cell surface receptor binding site
Kon Forward rate constant for the binding of a ligand
to a receptor binding site in solution
Koff Reverse rate constant for the dissociation of a li-
gand from a receptor binding site in solution
k+ Diffusion limited forward rate constant for the
binding of a ligand to a cell
km(O) Measured rate constant for dissociation at start
of the experiment
km(m) Measured rate constant for dissociation at com-
pletion of the experiment
K Equilibrium constant for binding of a ligand to a
receptor binding site (K = kf/k,= Kl/KOff)
L Concentration of free ligand in solution (nano-
molars)
LT Total concentration of ligand (nanomolar)
4e Concentration of free ligand at the start of the
experiment (nanomolars)
Leq Equilibrium concentration of free ligand at the
end of the experiment (nanomolars)
N Number of free receptor binding sites per cell
NT Total number of receptor binding sites per cell
NO Number of free receptor binding sites per cell at
the start of the experiment
NOq Equilibrium number of receptor binding sites per
cell at the end of the experiment (nanomolars)
p Cell concentration (cells/milliliters)
S Concentration of free receptor binding sites in
solution (nanomolars)
ST Total concentration of receptor binding sites in
solution (nanomolars)
SO Concentration of free receptor binding sites in
solution at the start of the experiment (nano-
molars)
S.q Equilibrium concentration of free receptor bind-
ing sites in solution at the end of the experi-
ment (nanomolars)
x Fraction of ligand dissociation that has occurred
by time t
nate (FITC) labeled IgE (Erickson et al., 1986). Here we
use this technique to measure the kinetics of dissociation.
Fig. 1 shows the results of a typical kinetic dissociation
experiment. Plotted is the relative fluorescence as a
function of time. Initially only RBL cells with FITC-IgE
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FIGURE 1 A typical kinetic dissociation experiment at 1 50C. At t = 0
RBL cells with 5.7 x 105 Fab sites/cell (2.85 x 105 FITC IgE/cell) are
present in solution. At t 82 s DCT is added to a final concentration of
13.2 nM. The DCT binds to the FITC-IgE, fills a large fraction of the
binding sites, and quenches the fluorescence (-20% of the total signal).
At t = 274 s solution receptor (unlabeled IgE) is added at a final
concentration of 942 nM, the DCT begins to dissociate and the
fluorescence starts to recover.
on their surface are present (the first plateau at - 9.2).
Next, a high concentration of the monovalent ligand DCT
is added. The DCT binds to the FITC-IgE quenching the
fluorescence and a new equilibrium is rapidly established
(the second plateau at - 7.2). Lastly, the solution recep-
tors (unlabeled monoclonal IgE) are added, and the
fluorescence recovers as the DCT dissociates from cell
surface IgE binding sites.
After the solution receptors are added, the fraction of
ligand dissociation that has occurred by time t, Eq. 13, is
related to the relative fluorescence by the expression
(18)
where Fmax is the value of the relative fluorescence after
dissociation has gone to completion (the third plateau at
-8.5), Fmin is the value of the relative fluorescence
immediately after the addition of unlabeled IgE, and F is
the relative fluorescence at time t. The addition of the
solution IgE alters the fluorescence. (If we add the
solution IgE before the DCT, the relative fluorescence
drops to -8.5.) This alteration cannot be accounted for by
dilution corrections alone. For this reason Fmin is lower
than the value of the second plateau, but its exact value is
unknown. This can be seen in Fig. 1 where the first three
data points after the start of dissociation are lower than
the original minimum fluorescence. From Eq. 18 it fol-
lows that
(19)
To see whether dissociation of ligand from IgE is slower
when these receptors are clustered on cells compared with
when they are in solution we first do a series of dissocia-
tion experiments with different concentrations of solution
(ST) and cell surface receptor (NT). As described below,
for each of these experiments we determine km(). (Re-
call that km(oo) is the off rate constant for dissociation of a
ligand from a cell surface receptor as dissociation goes to
completion.) To see if rebinding is occurring we also
determine km(oo) for dissociation of DCT from FITC-IgE
in solution, in the presence of large concentrations of
unlabeled IgE, when there are no cells present.
To determine km(m) from a fluorescence recovery
experiment we fit Eq. 19 to the data, calculating x
numerically from Eq. 14. In our nonlinear least squares
data fitting routine we take as free parameters: km(oo), 6,
Fmin, and Fmax. The parameters 6 and Fmin are sensitive to
the exact time at which the experiment starts, i.e., the
time at which the solution receptors are added. Small
errors in the starting time can lead to large errors in these
two parameters. In our experiment there is an uncertainty
in the starting time of -2 s and thus, there may be large
errors in the values we obtain for km(O) and 6. However,
the parameters km(o) and F.,, are unaffected by errors in
the starting time (see the Appendix for an explanation of
why this is so).
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FIGURE 2 Determination of the reverse rate constant km(oo) for disso-
ciation of DCT from cell surface FITC-IgE at 150C. The data are from
Fig. 1. Shown is the first 10 min of the fluorescence recovery, i.e., t= 0
corresponds to the time when unlabeled IgE is added. The solid curve
was obtained from a nonlinear least squares fit of Eq. 19 to the complete
recovery curve (483 data points going out to t = 1,159 s). The variable x
in Eq. 19 was calculated from Eq. 14 numerically. In the fitting
procedure the parameters km(oo), 8, F,, and F. were allowed to vary.
The best values for these parameters (in the least squares sense) were
found to be: km(oo) - 1.07 x 10-2 s-',6 0.63, Fw. = 6.90, and F.. =
8.48. The results of fitting thirteen such experiments are listed in Table
3.
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TABLE 2 Determination of the off rate constant KaO for
dissociation of DCT from FITC-1gE in solution from six
experiments
km(m)(X 10-2 S-1) ST(X 102 nM) LT(nM) K0ff(X 10-2 S'1)
2.70 7.90 15.6 2.65
2.64 4.00 15.8 2.54
2.75 2.40 16.1 2.57
2.75 1.61 16.1 2.50
2.63 3.20 16.0 2.50
2.73 4.00 16.0 2.62
2.56 ± 0.06
For DCT dissociating from FITC-IgE in solution in the presence of a
high concentration of unlabeled IgE, km(oo) = Kff + KOL, - K0ff(1 -
Lr/ST). K. and Kff are the forward and reverse rate constants for DCT
binding to a single IgE binding site, L4, is the final DCT concentration,
and L, and ST are the total concentrations of DCT and unlabeled IgE,
respectively. We determined km(oo) from a nonlinear least squares fit of
Eq. 19, with x - 1 - exp (-km(Xo)t), to dissociation experiments such as
the one shown in Fig.4. In addition, we also obtained values for F,, and
F,., (results not shown).
In Fig. 2 we show the theoretical fit (Eq. (19) with x
calculated from Eq. 14 to the dissociation experiment
shown in Fig. 1. In this experiment we used 8.8 x 106
cells/ml with an average receptor site concentration of
5.7 x 105 sites/cell, which corresponds to a solution
concentration of 8.35 nM. Dissociation was initiated by
the addition of solution receptors (unlabeled IgE) at a
final site concentration of 942 nM. From our fit we found
the following value for the dissociation rate constant:
km(oo) = 1.07 x 102 s-'. This is -2.4 times slower than
the dissociation constant we determined for DCT disso-
ciating from FITC-IgE in solution, where in six experi-
ments we found that K,ff = 2.56 ± 0.06 x 10-2 s-5 (see
Table 2). In all we carried out thirteen experiments
including the one shown in Fig. 1, where the dissociation
of DCT from cell surface FITC-IgE was initiated by the
addition of unlabeled solution IgE. The parameters deter-
mined from these experiments are given in Table 3.
Our theory predicts that as DCT dissociates from cell
surface binding sites its rate of dissociation constantly
decreases from an initial rate km(0) to a final rate km(o).
As time proceeds more surface sites become free, more
rebinding occurs, and dissociation slows. This slowing can
be seen in Fig. 3 where the data in Fig. 2 is replotted as a
log-linear plot of (1 - Fmax/Fmin) vs. t. The initial slope of
such a plot equals km(0) and the final slope approaches
km(oo). The solid line in Fig. 3 is the straight line fit to only
the first ten data points, corresponding to the first 25 s of
the experiment. The slope of this curve equals 1.60 x 102
s-'. This estimate of km(0) compares well with the
estimate obtained by fitting the complete curve in Fig. 2
where, from the determinations of a and km(oo), we have
that km(O) = bk(oo) = 1.69 x 10-2 S-'.
In Figs. 4 and 5 we carry out a similar analysis for the
dissociation ofDCT from FITC-IgE in solution. The solid
line in Fig. 5 is the straight line fit of the first 10 data
points (t < 25 s) with slope km(0) = 2.67 x 10-2 s-'.
Fitting the data for the entire curve in Fig. 4 yields km
(co) = 2.70 x 10-2 s-'. Unlike dissociation from cell
surface receptors (Figs. 2 and 3), we observe no system-
atic slowing when DCT dissociates from receptors in
solution.
Finally, we test how the variation in km(oo) with ST and
NT compares with that predicted by the theory. From Eqs.
TABLE 3 Least square estimates of the parameters k,(oo) and 6 for thirteen ligand (DCT)-cell surface receptor (FITC-IgE)
dissociation experiments
NT(X I05 sites/cell) ST(nM) Lr(nM) Seq(nM) km(c)(x 10-2 s-') 6
6.00 1540 13.0 1527 1.04 0.60
6.00 942 13.2 929 0.90 0.43
6.00 712 13.3 699 1.03 0.55
6.00 478 13.4 465 0.95 0.50
5.70 1540 13.0 1527 1.05 0.58
5.70 942 13.2 929 1.07 0.63
5.70 478 13.4 465 1.01 0.60
3.00 712 3.96 708 1.63 0.61
3.00 400 4.00 396 1.74 0.63
3.00 242 4.02 238 1.82 0.74
1.75 712 3.96 708 1.92 0.87
1.75 400 4.00 396 1.74 0.66
1.75 242 4.02 238 1.46 0.54
km(oo) is the reverse rate constant for dissociation of DCT from cell surface FITC-IgE at the end of the experiment when all binding sites are free. 6 =
km(oo)/km(O), where km(O) is the reverse rate constant for dissociation at the start of the experiment when a large fraction of the cell surface FITC-IgE
are bound. NT, ST, and Lr are the concentrations of cell surface FITC-IgE binding sites, the unlabeled solution IgE binding sites, and the DCT,
respectively. Sq is the final concentration of free unlabeled solution IgE binding sites and was estimated using Eq. 22. We use the data in the first four
columns to test Eq. 20 (see Fig. 6). In addition to determining km(oo) and 6 we also determined Fmin and F,..X, the maximum and minimum relative
fluorescence (results not shown).
Goldstein et al. Competition between Solution and Surface Receptors 961et al. Competition between Solution and Surface Receptors 961
0.1
ILL
0.01
100 100 150 200 250
Time (s)
FIGURE 3 The slowing of the rate of dissociation of DCT from cell
surface IgE. Our theory predicts that at short times a plot of ln(1 -F/
F,,) vs. t, where F is the relative fluorescence at time t and F,,, = 8.48
is the relative fluorescence after dissociation has gone to completion, will
be a straight line with slope equal to km(0), the initial dissociation rate.
(This follows from Eq. 17a. At short times, i.e., 1 >> km(0)t, x t km(0)t
and therefore, since k.(0)t is small, x -1 - exp (-km(0)t). Fitting a
straight line to the first ten data points (solid line) gives a slope of
1.60 x 10-2s-'. As t increases dissociation slows as can be seen by the
concave upward deviation of the data from the straight line. Because the
ln(1- F/F,) is infinite when F=F,,,, we cannot plot the long time data
for when F fluctuates above Fn. the function becomes undefined.
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FIGURE 4 Determination of the reverse rate constant km(oo) for the
dissociation of DCT from solution FITC-IgE at 150C. 8.8 nM of
FITC-IgE was allowed to equilibrate with 15.6 nM DCT. At t = 0
unlabeled IgE was added at a final concentration of 790 nM. The solid
curve was obtained from a nonlinear least squares fit of Eq. 19 to the
complete recovery curve (478 data points going out to t = 1147 s). In Eq.
19 we took x = 1 - exp(-km(oo)t). The parameter km(oo), Fj, and F..
were allowed to vary. The best fit values for these parameters (in the
least squares sense) were found to be: km(oo) = 2.70 x 10-2s-', F,j0 =
7.54 and F.. = 9.03. The results of six experiments are listed in Table
2.
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FIGURE 5 The rate of dissociation of DCT from solution FITC-IgE is
constant with time. Shown is a plot of ln(I -F/F,,,,) vs. t for the first
130 s of the data in Fig. 4 F is the relative fluorescence at time t and
F.. = 9.03 is the relative fluorescence after dissociation has gone to
completion. Fitting a straight line to the first data points (solid line)
gives a slope of 2.67 x 10-2 s-'. Fitting the data for the entire
experiment (see Fig. 4) gives km(oo) = 2.70 x 102 s-' time.
1 2b and 16 we see that the theory predicts that
k.(0o) = Koff(l + KLOq)
I + aN°q,1 + (47ra3aS,,)"/2
where
(20)
(21)
We show in the Appendix that for the large solution
receptor concentrations we use, the following approxima-
tions hold:
KL.q 4/rST
Neq NT(I - Lr/ST) (22)
Seq - ST(l - Lr/ST)
To test Eq. 20 we fit it to the data given in Table 3, taking
as free parameters the off rate constant for dissociation of
DCT from FITC-IgE in solution, Koff, and the lumped
parameter a = K00/(4irDa). We hold the RBL cell radius
fixed at 4 ,tm. The least squares fit to the data yields the
following values for the parameters: Koff = 2.73 x 10-2 s-1
and a = 6.91 x 10-6 sites-'. Because km(m) is a function
of two variables, the data are predicted to fall on a family
of curves rather than a single curve. In Fig. 6, two
particular curves are shown (solid lines). Both curves
were calculated from Eq. 20 using the best fit values of
the parameters. The upper curve was obtained from Eq.
20 by setting S,,q equal to the smallest value it takes on in
Table 3, while the lower curve was obtained by setting S,q
equal to the largest value it takes on in Table 3. If there
were no noise in the data, the theory predicts that all the
b Bpyia Jora Voum 56 Noeme
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*
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FIGURE 6 Variation of the reverse rate constant km(oo) with cell surface
FITC-IgE and solution unlabeled IgE. Plotted is km(Xo) vs. Ncq/(Seq)'1/2
for the data in Table 3. N.q is the concentration of free cell surface
FITC-IgE binding sites and S<q is the concentration of free unlabeled
IgE binding sites in solution, after dissociation has gone to completion.
In this plot Sq is in nanomolars and the units of N^q are 1 O sites/cell. A
nonlinear least squares fit of the theoretical expression for km(oo), Eq.
20, to the data in Table 3 with two free parameters and the cell radius
a = 4MAm, yielded: Kff = 2.73 x 10-2 s-' and a = 6.91 x 10-6 sites-'. The
solid curves were calculated from Eq. 20 using the best fit values for the
parameters, with a = 4 ,um. For the upper and lower curves respectively,
S¢q was held fixed at its smallest and highest value in Table 3. The theory
predicts that the data should fall on or between these curves.
data points should fall either on, or between these two
curves.
The value of 2.73 x 10 2 s'- for K0ff that we determined
from fitting Eq. (20) to the data in Table 3 agrees with
the value 2.56 x 102 s-' that we directly determined for
DCT dissociating from FITC-IgE in solution (see Table
2). Also, the value we determined for a is consistent with
what we know about the values of the individual parame-
ters that make up a. To estimate a we need to know K.n, D
and a. Because we know Koff, we chose to determine Kon by
determining the equilibrium constant K = K0n/K0ff for
DCT binding to FITC-IgE in solution (see Fig. 7). From
three experiments K = 1.86 ± 0.42 nM-1 and therefore,
for the value of Koff from Table 2, we have that Kon = 4.76 ±
1.19 x 10-2 nM-1 s-' = 7.91 ± 1.98 x 10-14 cm3/s. We
have not determined D directly, but for a small ligand
such as DCT at 150 C, we expect that D 5 - 10 x 10-6
cm2/s. The radius of an RBL cell a t 4,m. Putting these
values into the expression for a, Eq. 21, we find that a -
1.2 - 3.9 x 10-6 sites-'. From our fit of the data we
found a = 6.9 x 106 sites-', which is within experimen-
tal error of the estimated range.
DISCUSSION
We have presented a theory to describe the kinetics of
dissociation of ligands from cell surface receptors in the
presence of solution receptors that also bind the ligand. A
FIGURE 7 Equilibrium binding of DCT to FITC-IgE in solution at
150C. The FITC-IgE concentration was 8.8 nM. Plotted is the relative
fluorescence vs the total DCT concentration. The solid curve was
obtained from a nonlinear least squares fit of the data (see Materials
and Methods) and yielded an equilibrium constant K = 1.61 (nanomo-
lars)-'. Two additional experiments were performed with an FITC-IgE
concentration of 9.7 nM. For the three experiments K = 1.86 ± 0.42
(nM) '.
major result of the theory, Eqs. 5 and 6, is the prediction
of the dependence of the ligand-cell surface receptor
association and dissociation rate constants on the free cell
surface receptor concentration, N, and the free solution
receptor concentrations, S. In a dissociation experiment
when no solution receptor is present, dissociation of the
ligand from cell surface receptors may be much slower
than dissociation from a receptor in solution because the
ligand may rebind many times to free cell surface recep-
tors before achieving a true separation from the cell
surface. From Eq. 6 it follows that such rebinding will be
prevented from occurring when S >> N2K00/(167r2Da4).
Note that this inequality is independent of the size of the
receptor. The effective concentration of the surface recep-
tors that the solution receptors need to overcome, is not, as
one might have guessed, simply the surface site density
divided by the height of the receptor. The effective
concentration does not depend linearly on N, but rather is
proportional to N2. For our experimental system the
single-site forward rate constant K., = 7.9 x I0-'4 cm3/s
at 1 5oC and the RBL cell radius a k 4 ,um. We have not
determined the diffusion coefficient of the ligand (DCT)
but a reasonable estimate for D at 1 5sC is 5 x 10-6 cm2/s.
For these parameter values we predict that ifN = 6 x 105
sites/cell, then to prevent rebinding S >> 2,400 nM. When
we carried out dissociation experiments in the presence of
solution receptor concentrations ranging from 1,540 to
478 nM, the rate constant for dissociation of DCT from
cell surface IgE was - 2.5 times slower than for dissocia-
tion from solution IgE. As we lowered the cell surface
receptor density the rate of dissociation from cell surface
IgE increased, but even for N = 1.75 x 105 sites/cell and
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S = 712-242 nM, the reverse rate constant was substan-
tially slower than for dissociation from solution IgE.
These results are summarized in Table 3.
Another prediction of the theory is that as the ligand
dissociates from cell surface binding sites the rate con-
stant for dissociation decreases from an initial rate km(0)
to a final rate km(oo), because with time more surface
binding sites become free and more rebinding occurs. We
were able to demonstrate directly that this slowing down
occurs (see Fig. 3). Typically, in our experiments where a
large fraction of surface receptor sites were initially
bound, the rate of dissociation slowed by a factor of two
during the course of dissociation. Finally, we were able to
test the predicted form for the rate constant, Eq. 6, and
show it was consistent with experiment. However, the
experimental errors were such that this was not a rigorous
test of the theory.
The system we studied exhibited rebinding effects, i.e.,
a reduction in the reverse rate constant for ligand-cell
surface IgE dissociation, at high IgE concentrations
(.1.0 x 1O' sites/cell). Previously we showed that the
forward rate constant decreased with increasing cell
surface IgE concentration (Erickson et al., 1987). A
similar effect had been seen for the binding of phage
lambda to receptors on Escherichia coli (Schwartz,
1976). Recently Wiley (1988) observed that dissociation
of epidermal growth factor (EGF) from its receptor on
A431 cells (2 - 4 x 106 EGF sites/cell) was much
slower when the initial number of EGF receptor sites
bound was smaller than when most of the sites were filled.
Abbot and Nelsestuen (1987) observed binding in the
diffusion limit of blood coagulation factor Va light chain
to its receptor on membrane vesicles. We expect that for
many systems the kinetics of binding and dissociation are
altered at high cell surface receptor densities. The theory
presented here shows how the presence of solution recep-
tors that compete with the cell surface receptors for the
ligand, further changes the kinetics.
APPENDIX
Diffusive rate constant in the
presence of solution receptors
To obtain the diffusive rate constant k+ for the binding of a ligand with
diffusion coefficient D, to a cell of radius a, in the presence of solution
receptors whose free binding site concentration is S, we calculate the
steady state flux into a perfectly absorbing sphere of radius a. Because
the sphere is perfectly absorbing, at the surface of the sphere the free
ligand concentration is zero, i.e., C(a) - 0. Far from the sphere C is
finite. We modify the standard formulation of Smoluchowski in two
ways. (a) Outside the sphere we allow ligands to both diffuse and be
absorbed by solution receptors. (b) To maintain a steady state we insert
ligands at a constant rate Q uniformly throughout space to replace the
ligands that are absorbed by either the sphere or the solution receptors.
In the Smoluchowski approach a steady state is maintained by holding
the ligand concentration constant at infinity. Once solution receptors are
introduced that absorb ligands uniformly outside the sphere, it is no
longer possible to maintain a nonzero steady state in this way. If KO is the
forward rate constant for the binding of a ligand to a receptor in solution
then in the steady state
0 = DV2C - KO,SC + Q, (Al)
where we have assumed that S is sufficiently large so that dissociation
from solution receptors can be neglected. In particular, this requires that
the distance a ligand travels when it is free, NID/(KOS), be small
compared with the distance it travels when it is bound to a receptor,
ND~sKOff, where Ds is the diffusion coefficient of the ligand-receptor
complex. Thus, a necessary condition for Eq. Al to be valid is that KS>>
D/DS (Dembo and Goldstein, unpublished result). For our ligand
(DCT) and receptor (IgE), D/Ds5 102, and K - 2 nM-'. Thus, we
require that S >> 50 nM.
Because there is spherical symmetry, Eq. Al can be written as
follows:
r2 dr[rd-r 2+ D (A2)
where the screening length X = VD/(K,xS), and r is the radial distance
from the center of the sphere. We shall assume that S can be treated as
being constant in space, i.e., that S is sufficiently large that the binding
of the ligand takes up a negligible fraction of free solution receptor sites.
With the given boundary conditions, and taking S constant, the solution
to Eq. A2 is
C(r) = C4 I a e-(r-a)IX (A3)
where C, = QI(K.S).
The rate constant k+ equals the flux into the sphere divided by the
average concentration outside the sphere, i.e.,
4irDa2dC/dr
C. (A4)
where dC/dr is evaluated at r = a. Thus, from Eqs. A3 and A4 we find
that
k+ = 4irDa[l + a/X) = 47rDa[l + (KO,,Sa2/D)'1/2]. (AS)
Note that in the limit that S - 0, we recover the standard result that k+
= 4wDa.
Although at first it may seem surprising that the presence of solution
receptors that bind the ligand increases k+, we can see from Eq. A4 why
this is so. The presence of solution receptors increases the gradient of the
ligand concentration in the vicinity of the absorbing sphere. In the
presence of solution receptors most of the variation in c(r) occurs within
a few screening lengths of the cell surface. In terms of the screening
length Eq. 4 becomes k+ = 47rDa(1 + a/X). When A is comparable with
or smaller than the cell radius, k+ in the presence of solution receptors
differs appreciably from k+ when they are absent.
Effect on parameter estimation of
errors in the initial starting time
After a short initial transient x is given by Eq. 1 7b and therefore at long
times Eq. 19 becomes
F = Fm - (Fmax - Fmin)e -m' ). (BI)
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Suppose that there is an error in the starting time so that the
experiments starts at t = to rather than at t = 0. Then the correct
expression for F is
F= Fmx-(FFmax - Fmin)e -k.()(t-to) (B2)
Note however that both Eqs. B 1 and B2 are of the same form, i.e.,
F= Fmax-Ae-k(t , (B3)
where A is a lumped parameter. Thus if we fit the same data with Eq.
Bi, allowing F., Fm,J and km(oX) to be free parameters, or Eq. B2,
allowing F., Fm,, km(-) and to to be free parameters, we will obtain the
same values for F., km(oo) and A.
Because Eq. B 1 is not correct at very short times, the argument we
have presented is not rigorous, but it strongly suggests that when we use
Eq. 19 with the correct expression for x, Eq. 14, errors in to will have
little effect on the values obtained for F,., and km(oo). To see if this is so
we have fit Eq. 19 to all the cell dissociation experiments using two
different expressions for x. First we fit the data using Eq. 14 to calculate
x, the results of which are given in Table 2. Then we introduced an
additional free parameter to by changing t to t-to in Eq. 14 and refit all
the data (results not shown). The values we obtained for Fx, and k(x)
did not change while the values of 6 and F,,,,, did.
Approximate values for L,q, Neq
and S,q
At equilibrium dN/dt = dS/dt =0 in Eqs. 8 and 9 andN = NE,q, S = Seq
and L = Leq in Eqs. 8-10. We are interested in the case when we add a
large concentration of solution receptors (KSq », 1) that bind most of
the ligand so that the free ligand concentration is close to zero, i.e., 1 >>
KL.q. For this to hold we must have ST BP Lr. From Eqs. 8 and 9 it follows
that
Neq= NT NT(1-KLeq) (C1)1q + KLq
Seq = 1 +
-L ST(l - KLO9). (C2)
Substituting these expressions into Eq. 10 and solving for Leq we obtain
the following result
KLeq ~KLT LT4 I1+KNT]
1 + KNT + KST ST [ KST . (C3)
It follows from Eq. C3 that KLeq LT/ST when ST >> NT. In all our cell
dissociation experiments (see Table 2) the concentrations where chosen
so that KST »> 1, ST»>>NT, and ST >> LT.
Conditions for validity of the
quasi-equilibrium approximation
(QEA)
To obtain conditions for when the use of the QEA is valid in deriving Eq.
14 we follow Segel and Slemrod (1989). In what follows we assume that
the solution receptor concentration is in large excess, i.e., ST >> LT and
ST » NT.
We expect that after the solution receptor is added there will be an
initial transient as ligands in solution bind to these added receptors. At
very short times the binding will appear irreversible, i.e.,
dL
dT A-, KoSTL' (DI)
where at t = 0, S = ST. Thus, the characteristic time of this initial
transient is tc = 1 (K.ST).
We want the duration of this transient to be short compared with the
characteristic time it takes for the ligand to dissociate from the cell
surface. When we solved Eq. 8 in the QEA we found that at long times
(Eq. 17b) the rate of decay of ligand bound on the surface equals km(X)
= (Kff + K. Lq)/(( + 4Nq). Therefore the characteristic time for this
slow dissociation ts = 1 /km(oo). The condition that ts >> tc is therefore
that
IAN/NOI - (dN/dt)1,, x tc. (D3)No
If at t = 0 we neglect any binding to the surface then from Eq. 8
(dN/dt),.X A krNT(I - No/NT) JlD3)
-(dN/dt)1M0 x tc, AZn (D4)No 1+4NO KST nO
where no = No/NT. Thus for the initial condition we used to be valid in
the QEA we must have
(1 + KNo)KST>> (1 - no)/no. (D5)
The largest ligand concentration we used was 13.4 nM. For this value of
Lo we estimate that no - 0.04. Because K - 2 nM-' this condition
requires that (1 + 4NO)KST - 24 nM. Because tNo is small we
therefore need ST . 12 nM. This condition is more restrictive than the
first condition, Eq. D2. When we compare numerical solutions of Eqs.
8-10 with results obtained from the QEA, Eq. 14, we find that we get
good agreement for ST 2 200 nM.
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